Abstract:ID 131189 Poster Board 456 Medulloblastoma is the most common malignant pediatric brain tumor, accounting for nearly 20% of all CNS neoplasms in children. The disease comprises four distinct subtypes: SHH, WNT, Group 3, and Group 4. The Group 3 and Group 4 subtypes account for around 60% of all cases and are characterized by unfavorable prognosis, poor treatment outcome, and a higher prevalence in males than females. The genetic underpinning of medulloblastoma has not been fully understood and the intricacies of its genetic architecture warrant in-depth exploration to enhance our understanding of tumorigenesis and enable better therapeutic strategies. In this investigative study, our primary objective was to discover prominent Single Nucleotide Polymorphisms (SNPs) enriched in medulloblastoma patients on chromosome X for which hypermutation has been implicated in tumorigenesis. Employing genomic analysis techniques, we meticulously aligned sequences to genes situated on chromosome X, drawing from a comprehensive cohort of medulloblastoma patients from the public database Sequence Read Archive (SRA) to the reference human genome sourced from Ensembl. Cross-referenced mutations were identified and analyzed using Python genome analysis programs and statistical assessments to discern variant associations between our medulloblastoma and control groups were undertaken using chi-square tests. Our analysis brought to the forefront genes FTX, CROCCP1, TTC3P1, KANTR, and AP2B1P, all of which exhibited pronounced SNP concentrations in medulloblastoma patients. The FTX gene exhibited significant results, with over 200 unique SNPs identified. Following closely, the CROCCP1, TTC3P1, KANTR, and AP2B1P genes were each found to have between 120 and 140 unique SNPs. Intriguingly, while these genes have received peripheral attention in prior medulloblastoma-centric research, our findings bring to light their potential importance in the disease's genetic landscape. FTX and KANTR are both genes that regulate the production of LncRNAs which, despite not encoding for proteins, may play a significant role in gene expression and have been found to regulate tumor suppression and promotion. CROCCP1, TTC3P1, and AP2B1P, on the other hand, are pseudogenes, which may influence regulatory networks. Though once believed to have little impact on protein function, pseudogenes have recently been found to influence gene expression regulation and microRNA activity, which can therefore play roles in tumor suppression. Our findings underscore the influence of specific genes and their associated SNPs, emphasizing their prospective roles in disease onset, progression, and potential therapeutic interventions for medulloblastoma patients.

Genes differentially expressed in medulloblastoma and fetal brain

Identification of Novel Human Glioblastoma-Specific Transcripts by Serial Analysis of Gene Expression Data Mining

Cnsc-03. High Expression Of Piccolo And Syntaxin-1A In Paediatric Medulloblastoma Due To Both: High Neuronal Fraction And Endogenous Expression

High Expression of GABAA Receptor β Subunit Genes Is Associated with Longer Overall Survival in Medulloblastoma

Identification of Differential Splicing Genes in Gliomas Using Exon Expression Profiling.

Human Fetal Cerebellar Cell Atlas Informs Medulloblastoma Origin and Oncogenesis

High SNP concentrations on the X-chromosome suggest prospective gene targets FTX, CROCCP1, TTC3P1, KANTR, and AP2B1P in medulloblastoma

ASPM gene expression in medulloblastoma

Epco-30. Transcriptomic Analysis Identifies Regional Biology And Outcome Heterogeneity In Medulloblastoma And Ependymoma Subtypes

Identification and Validation of a 23-Gene Expression Signature for Subtype Classification of Medulloblastoma.

Bioinformatic Analysis of Gene Expression Related to Sialic Acid Biosynthesis in Patients With Medulloblastoma

Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma

Differential Expression of Somatostatin Receptors in Medulloblastoma

Identification of a Novel Homozygous Deletion Region at 6q23.1 in Medulloblastomas Using High-Resolution Array Comparative Genomic Hybridization Analysis

High-Resolution Array-Based Comparative Genomic Hybridization of Medulloblastomas and Supratentorial Primitive Neuroectodermal Tumors

Ezh2 Delays Activation of Differentiation Genes During Normal Cerebellar Granule Neuron Development and in Medulloblastoma

Dissecting the genomic complexity underlying medulloblastoma

CCND2, CTNNB1, DDX3X, GLI2, SMARCA4, MYC, MYCN, PTCH1, TP53, and MLL2 gene variants and risk of childhood medulloblastoma

Single‐Cell Chromatin Accessibility Analysis Reveals Subgroup‐Specific TF‐NTR Regulatory Circuits in Medulloblastoma

Differential Expression of Notch Family Members in Astrocytomas and Medulloblastomas

Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time quantitative PCR